Form 4: IGM Biosciences CFO Sells Shares for Tax Obligations

IGM Biosciences' Chief Financial Officer, Misbah Tahir, sold 8,741 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Misbah Tahir, Chief Financial Officer of IGM Biosciences, Inc. (IGMS), sold 8,741 shares of common stock.
• The transaction occurred on July 23, 2025, at a weighted average price of $1.2728 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following this transaction, Misbah Tahir beneficially owns 170,061 shares of IGM Biosciences common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale to cover tax obligations upon RSU vesting, which is neutral in sentiment and does not indicate a change in management's confidence or company performance.

Future Outlook

No future outlook or guidance is provided in this Form 4 filing, as it pertains solely to an individual insider transaction.

Industry Context

This filing details a routine insider transaction for tax purposes, which is a common occurrence across all industries when executives' restricted stock units vest. It does not reflect broader industry trends or specific company performance.

Stakeholder Impact

• Minimal impact on shareholders, employees, customers, suppliers, or creditors as it is a small, routine, non-discretionary sale for tax purposes.

Key Dates

Recommendation

The filing details a routine, non-discretionary sale of shares by the CFO to cover tax obligations upon the vesting of restricted stock units. This type of transaction is common and does not reflect a change in the company's fundamentals or the insider's confidence. Therefore, it provides no new information that would warrant a change in investment recommendation; a 'hold' stance is maintained based solely on this filing.

Keywords

IGM Biosciences, IGMS, Form 4, Insider Trading, Stock Sale, CFO, Misbah Tahir, Restricted Stock Units, Tax Withholding, Biotechnology